Company Filing History:

13 out of 149

Boehringer Ingelheim Pharma Kg

patents

3 out of 197

Boehringer Ingelheim Kg

patents

1 out of 9

C. H. Boehringer Sohn

patents

4. 1 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

Years Active: 1983-2005

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6855713 - Benzimidazole derivatives, a process for their manufacture and use as a medicine (2005-02-15),

2. 6780863 - Bis-basic compounds with tryptase-inhibitory activity (2004-08-24),

3. 6656956 - Benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions (2003-12-02),

4. 6576669 - Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes (2003-06-10),

5. 6528491 - Pyranoside derivatives (2003-03-04),

6. 6512000 - Aminocarbonyl-substituted benzimidazoles having tryptase-inhibitory activity (2003-01-28),

7. 6489359 - Sulphoxybenzamides (2002-12-03),

8. 6413990 - Arylsulphonamide-substituted benzimidazoles having tryptase-inhibiting activity (2002-07-02),

9. 6407130 - Carboxamide-substituted benzimidazoles having tryptase-inhibiting activity (2002-06-18),

10. 6365584 - Arylysulphonamide-substituted benzimidazoles having tryptase-inhibiting activity (2002-04-02),

11. 6288277 - Benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments (2001-09-11),

12. 6265612 - Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect (2001-07-24),

13. 6197824 - Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect (2001-03-06),

14. 6197753 - Pyranoside derivatives (2001-03-06),

15. 6133479 - Phenylethylamine derivatives, processes for preparing them and their use (2000-10-17),

Title: The Innovative Journey of Hans Michael Jennewein

Introduction: Hans Michael Jennewein, a prolific inventor based in Wiesbaden, DE, has made significant contributions to the field of medicine through his 18 patents and groundbreaking inventions.

Latest Patents:

1. Benzimidazole derivatives, a process for their manufacture and use as a medicine: Jennewein's recent patent revolves around benzimidazole derivatives with trypsin-inhibiting action, showcasing his expertise in medicinal chemistry.

2. Bis-basic compounds with tryptase-inhibitory activity: Another notable invention by Jennewein, highlighting his focus on developing compounds with therapeutic benefits.

Career Highlights: Jennewein has worked with renowned pharmaceutical companies like Boehringer Ingelheim Pharma KG and Boehringer Ingelheim KG, where he honed his skills and brought his innovative ideas to life in the healthcare sector.

Collaborations: Throughout his career, Jennewein has collaborated with talented individuals such as Ralf Anderskewitz and Franz Birke, fostering a culture of innovation and teamwork in his research endeavors.

Conclusion: Hans Michael Jennewein's remarkable journey as an inventor underscores his passion for advancing medicine through cutting-edge inventions. His patents and collaborations exemplify his dedication to pushing the boundaries of scientific discovery in the pursuit of improving healthcare outcomes for all.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com